July 1, 2025 · Form 4 insider transaction
Lamy Patrick sold 2,000 shares of Akero Therapeutics, Inc. at $52.88 per share, a transaction worth $105.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 6, 2025, previously adopted by the Reporting Person.